Moxifloxacin vs. Polytrim for Conjunctivitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00581542|
Recruitment Status : Completed
First Posted : December 27, 2007
Results First Posted : January 18, 2016
Last Update Posted : January 18, 2016
|Condition or disease||Intervention/treatment||Phase|
|Conjunctivitis||Drug: moxifloxacin Drug: polytrim||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||124 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.|
|Study Start Date :||March 2007|
|Primary Completion Date :||March 2009|
|Study Completion Date :||March 2012|
|Active Comparator: Moxifloxacin Opthalmic solution||
1-2 drops four times a day for 8-10 days.
|Active Comparator: Polymyxin B-trimethoprim opthalmic solution||
1-2 drops three times a day for 8-10 days.
- Number of Participants With Normal Physical Examination of the Eye [ Time Frame: 10 days ]
- Number of Participants With a Negative Bacterial Culture [ Time Frame: 10 days ]Conjunctival swab specimens were inoculated onto tryptic soy agar with 5% sheep blood and GC II agar supplemented with hemoglobin and isovialex with incubation at 35 degrees C in ambient air supplemented with 5% carbon dioxide for 48 hours. S pneumoniae, H influenzai and M Catarrhalis were identified.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00581542
|United States, New York|
|University of Rochester|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Francis Gigliotti, MD||University of Rochester|